Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
3.180
+0.050 (1.60%)
Nov 21, 2024, 4:00 PM EST - Market closed
Zentalis Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 227 | 1,072 | 1,149 | 3,808 | 2,109 | - | |
| Market Cap Growth | -81.53% | -6.72% | -69.82% | 80.54% | - | - | |
| Enterprise Value | -125 | 601 | 775 | 3,443 | 1,769 | - | |
| Last Close Price | 3.13 | 15.15 | 20.14 | 84.06 | 51.94 | - | |
| PB Ratio | 0.63 | 2.45 | 2.65 | 10.45 | 6.33 | - | |
| P/TBV Ratio | 0.75 | 2.47 | 2.67 | 10.57 | 7.13 | - | |
| Debt / Equity Ratio | 0.12 | 0.10 | 0.11 | 0.13 | 0.01 | 0.01 | |
| Quick Ratio | 7.13 | 6.96 | 7.72 | 7.73 | 11.85 | 4.52 | |
| Current Ratio | 7.29 | 7.16 | 7.98 | 7.98 | 12.07 | 4.62 | |
| Return on Equity (ROE) | -42.89% | -67.09% | -59.39% | -47.60% | -59.01% | -92.09% | |
| Return on Assets (ROA) | -25.24% | -28.53% | -28.59% | -31.67% | -32.78% | -45.58% | |
| Return on Capital (ROIC) | -28.27% | -32.27% | -31.86% | -34.82% | -36.70% | -57.69% | |
| Earnings Yield | -82.35% | -27.25% | -20.60% | -4.17% | -5.59% | - | |
| FCF Yield | -79.07% | -19.44% | -14.47% | -4.21% | -4.15% | - | |
| Buyback Yield / Dilution | -14.04% | -23.75% | -23.82% | -51.84% | -402.29% | -0.05% | |
| Total Shareholder Return | -14.04% | -23.75% | -23.82% | -51.84% | -402.29% | -0.05% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.